Matrix metalloproteinase-1 (MMP-1) promoter polymorphisms are well linked with lower stomach tumor formation in eastern Indian population

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Dey, Sanjib ^a   Ghosh, Nillu ^a   Saha, Debjit ^a   Kesh, Kousik ^a   Gupta, Arnab ^b   Swarnakar, Snehasikta ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Research Institute   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INDIAN; LOWER STOMACH CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MATRIX METALLOPROTEINASE 1 GENE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; TRANSCRIPTION INITIATION SITE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; HAPLOTYPES; HUMANS; INDIA; LINKAGE DISEQUILIBRIUM; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; STOMACH; STOMACH NEOPLASMS;

EID: 84895540562     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088040     Document Type: Article

References (50)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127: 2893-2917.
2. Dikshit RP, Mathur G, Mhatre S, Yeole BB (2011) Epidemiological review of gastric cancer in India. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 32: 3-11.
3. Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49: 347-353.
4. Park CC, Bissell MJ, Barcellos-Hoff MH (2000) The influence of the microenvironment on the malignant phenotype. Molecular Medicine Today 6: 324-329. (Pubitemid 30619340)
5. Lukashev ME, Werb Z (1998) ECM signalling: orchestrating cell behaviour and misbehaviour. Trends in Cell Biology 8: 437-441. (Pubitemid 28529716)
6. Vincenti MP, White LA, Schroen DJ, Benbow U, Brinckerhoff CE (1996) Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): Mechanisms that control enzyme activity, transcription, and mRNA stability. Critical Reviews in Eukaryotic Gene Expression 6: 391-411. (Pubitemid 26422410)
7. Pulukuri SM, Rao JS (2008) Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis. International journal of oncology 32: 757-765. (Pubitemid 351780586)
8. Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. Journal of the National Cancer Institute 89: 1260-1270. (Pubitemid 27371946)
9. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, et al. (1991) Distribution of Collagenase and Tissue Inhibitor of Metalloproteinases (Timp) in Colorectal Tumors. International Journal of Cancer 49: 666-672.
10. Murray GI, Duncan ME, Arbuckle E, Melvin WT, Fothergill JE (1998) Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 43: 791-797. (Pubitemid 28539658)
11. Murray GI, Duncan ME, O'Neil P, McKay JA, Melvin WT, et al. (1998) Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. Journal of Pathology 185: 256-261. (Pubitemid 28320046)
12. Baker EA, Leaper DJ (2003) The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology. European Journal of Cancer 39: 981-988. (Pubitemid 36428631)
13. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, et al. (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Research 58: 5321-5325. (Pubitemid 28551108)
14. Nishioka Y, Kobayashi K, Sagae S, Ishioka S, Nishikawa A, et al. (2000) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Japanese Journal of Cancer Research 91: 612-615. (Pubitemid 30453788)
15. Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, et al. (1999) Correlation between expression of the Matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Research 59: 4225-4227. (Pubitemid 29418732)
16. Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, et al. (2001) Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clinical Cancer Research 7: 2344-2346. (Pubitemid 32751634)
17. Hinoda Y, Okayama N, Takano N, Fujimura K, Suehiro Y, et al. (2002) Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. International Journal of Cancer 102: 526-529. (Pubitemid 35316009)
18. Zinzindohoue F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, et al. (2005) Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. Clinical Cancer Research 11: 594-599. (Pubitemid 40116884)
19. Elander N, Soderkvist P, Fransen K (2006) Matrix metalloproteinase (MMP)-1, -2,-3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Research 26: 791-795. (Pubitemid 43206050)
20. Hettiaratchi A, Hawkins NJ, McKenzie G, Ward RL, Hunt JE, et al. (2007) The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer. British Journal of Cancer 96: 783-792. (Pubitemid 46376634)
21. Zhu Y, Spitz MR, Lei L, Mills GB, Wu XF (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Research 61: 7825-7829. (Pubitemid 33049371)
22. Terry CF, Loukaci V, Green FR (2000) Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. Journal of Biological Chemistry 275: 18138-18144. (Pubitemid 30414764)
23. Frisdal E, Klerkx AHEM, Le Goff W, Tanck MWT, Lagarde JP, et al. (2005) Functional interaction between-629C/A,-971G/A and-1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study. Human Molecular Genetics 14: 2607-2618. (Pubitemid 41300635)
24. Pearce EG, Laxton RC, Pereira AC, Ye S (2007) Haplotype effects on matrix metalloproteinase-1 gene promoter activity in cancer cells. Molecular Cancer Research 5: 221-227. (Pubitemid 46569774)
25. Inoue T, Yashiro M, Nishimura S, Maeda K, Sawada T, et al. (1999) Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. International Journal of Molecular Medicine 4: 73-77.
26. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61: 7825-7829. (Pubitemid 33049371)
27. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. American journal of human genetics 81: 559-575. (Pubitemid 47330214)
28. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. (Pubitemid 40202029)
29. Schlesselman JJ (1982) Equation 6.9 and 6.10: Study Power with an Unequal Case-Control Ratio. Case-Control Studies: Design, Conduct, Analysis. USA: Oxford University Press Inc. 150-152.
30. Matsumura S, Oue N, Kitadai Y, Chayama K, Yoshida K, et al. (2004) A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer. J Cancer Res Clin Oncol 130: 259-265. (Pubitemid 38680266)
31. Albayrak S, Canguven O, Goktas C, Aydemir H, Koksal V (2007) Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population. Urol Int 79: 312-315. (Pubitemid 350136516)
32. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229. (Pubitemid 34680308)
33. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, et al. (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. Journal of Biological Chemistry 271: 13055-13060. (Pubitemid 26175880)
34. Ye S, Dhillon S, Turner SJ, Bateman AC, Theaker JM, et al. (2001) Invasiveness of cutaneous malignant melanoma is influenced by Matrix Metalloproteinase 1 gene polymorphism. Cancer Research 61: 1296-1298. (Pubitemid 34292545)
35. Miao XP, Xing DY, Tan W, Qi J, Lu WF, et al. (2002) Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk chinese population. Cancer Epidemiology Biomarkers & Prevention 11: 1454-1458. (Pubitemid 35340384)
36. Zhang JH, Li Y, Wang R, Geddert H, Guo W, et al. (2003) NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World Journal of Gastroenterology 9: 1390-1393. (Pubitemid 36992319)
37. Zhang JH, Li Y, Wang R, Wen DG, Sarbia M, et al. (2003) Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. International Journal of Cancer 105: 281-284. (Pubitemid 36505334)
38. Fong YC, Dutton CM, Cha SS, Garamszegi N, Sim FH, et al. (2004) Absence of a correlation between the presence of a single nucleotide polymorphism in the matrix metalloproteinase 1 promoter and outcome in patients of chondrosarcoma. Clinical Cancer Research 10: 7329-7334. (Pubitemid 39487722)
39. Benbow U, Tower GB, Wyatt CA, Buttice G, Brinckerhoff CE (2002) High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells. Journal of Cellular Biochemistry 86: 307-319. (Pubitemid 34743387)
40. Jin X, Kuang G, Wei LZ, Li Y, Wang R, et al. (2005) No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China. World Journal of Gastroenterology 11: 2385-2389. (Pubitemid 40667969)
41. Fang SM, Jin X, Wang R, Li Y, Guo W, et al. (2005) Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis 26: 481-486. (Pubitemid 40246571)
42. Przybylowska K, Zielinska J, Zadrozny M, Krawczyk T, Kulig A, et al. (2004) An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymphnode metastasis in breast cancer. Journal of Experimental & Clinical Cancer Research 23: 121-125. (Pubitemid 38552606)
43. Woo M, Park K, Nam J, Kim JC (2007) Clinical implications of matrix metalloproteinase-1,-3,-7,-9,-12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. Journal of Gastroenterology and Hepatology 22: 1064-1070. (Pubitemid 47019841)
44. Singer CF, Marbaix E, Kokorine I, Lemoine P, Donnez J, et al. (1997) Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1alpha and its dual block by ovarian steroids. Proceedings of the National Academy of Sciences of the United States of America 94: 10341-10345. (Pubitemid 27407043)
45. Ito R, Kitadai Y, Kyo E, Yokozaki H, Yasui W, et al. (1993) Interleukin-1-Alpha Acts as an Autocrine Growth Stimulator for Human Gastric-Carcinoma Cells. Cancer Research 53: 4102-4106. (Pubitemid 23267718)
46. Tomimatsu S, Ichikura T, Mochizuki H (2001) Significant correlation between expression of interleukin-la and liver metastasis in gastric carcinoma. Cancer 91: 1272-1276. (Pubitemid 32267037)
47. Wyatt CA, Coon CI, Gibson JJ, Brinckerhoff CE (2002) Potential for the 2G single nucleotide polymorphism in the promoter of matrix metalloproteinase to enhance gene expression in normal stromal cells. Cancer Research 62: 7200-7202. (Pubitemid 36025238)
48. Ito T, Nakayama T, Ito M, Naito S, Kanematsu T, et al. (1998) Expression of the ets-1 proto-oncogene in human pancreatic carcinoma. Modern Pathology 11: 209-215. (Pubitemid 28144158)
49. Nakayama T, Ito M, Ohtsuru A, Naito S, NakashimaM, et al. (1999) Expression of the ets-1 proto-oncogene in human thyroid tumor. Modern Pathology 12: 61-68. (Pubitemid 29059168)
50. Pearce E, Tregouet DA, Samnegard A, Morgan AR, Cox C, et al. (2005) Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circulation Research 97: 1070-1076. (Pubitemid 41668921)